Hopefully, but RTS,S (Mosquirix) seems to have a 30 to 40
percent efficacy and has to be used with
conventional medicaments. The administration of four
doses and a booster to infants, and the sheer difficulty of
keeping the necessary temperature is also a challenge.
There is a bit of hype by GlaxoSmithKline and the WHO.
Afterall this vaccine has its beginnings in 1987 by Manuel Pattarroyo,
a Columbian professor.
Perhaps this present wall-to wall coverage diverts attention from the
paltry donations of covid19 vaccines. Or perhaps not.
Whatever the case, they are selling this one as a Christmas present
to Africa. South Asia, Southeast Asia, South America,
the Caribbean, and the Pacific are malaria regions, too,
and I expect that they will get some of the anticipated
benefits from it, too, granted that Africa has the majority of cases.
Prof. Gloria Emeagwali
Professor Gloria Emeagwali
Prof. of History/African Studies, CCSU
africahistory.net; vimeo.com/ gloriaemeagwali
Recipient of the 2014 Distinguished Research
Excellence Award, Univ. of Texas at Austin;
2019 Distinguished Africanist Award
New York African Studies Association
Prof. of History/African Studies, CCSU
africahistory.net; vimeo.com/ gloriaemeagwali
Recipient of the 2014 Distinguished Research
Excellence Award, Univ. of Texas at Austin;
2019 Distinguished Africanist Award
New York African Studies Association
From: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com> on behalf of Elias K. Bongmba <bongmba@rice.edu>
Sent: Thursday, October 7, 2021 9:44 AM
To: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com>
Subject: Re: USA Africa Dialogue Series - Malaria vaccine
Sent: Thursday, October 7, 2021 9:44 AM
To: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com>
Subject: Re: USA Africa Dialogue Series - Malaria vaccine
Please be cautious: **External Email**
This is a real breakthrough and a spectacular development that could be
a game changer that will save millions of lives and strengthen the fight
against malaria.
Elias
On 10/6/2021 3:35 PM, Toyin Falola wrote:
> https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nytimes.com%2F2021%2F10%2F06%2Fhealth%2Fmalaria-vaccine-who.html%3FreferringSource%3DarticleShare&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082251399%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=%2Fk3tRyvt8ACkSYftEAjEZ7ICVmr6XyIZJ6WnLDdxrcA%3D&reserved=0
>
>
> Sent from my iPhone
>
--
Elias Kifon Bongmba PhD, DTheo (Lund)
Harry and Hazel Chair in Christian Theology
Professor of Religion
Chair, Department of Religion
Executive Editor, the Journal of Religion in Africa
Rice university
PO Box 1892 Houston TX 77251-1892
https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Freli.rice.edu%2Ffaculty%2Felias-kifon-bongmba&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=nA3%2B%2Bo9p7q0hmHWcn7Yi6QsKR%2B2E23YLCPR%2FbZ1Ps74%3D&reserved=0
--
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fgroups.google.com%2Fgroup%2FUSAAfricaDialogue&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0M6vig0sRNmRsClmMrU6MoHB7cCkuD44zo0LhfcGVug%3D&reserved=0
Early archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.utexas.edu%2Fconferences%2Fafrica%2Fads%2Findex.html&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3fnQDLspMqd0Omt1D28%2Fq4D%2FZveBoWeQP80%2FT27ssSg%3D&reserved=0
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgroups.google.com%2Fd%2Fmsgid%2Fusaafricadialogue%2F6fad9e72-e5f8-3d82-74de-3b8acdaae1ce%2540rice.edu&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=EmjeC4o504oz2NJSKQH7LrN4xAbSRePp5FwQhtA11MY%3D&reserved=0.
This is a real breakthrough and a spectacular development that could be
a game changer that will save millions of lives and strengthen the fight
against malaria.
Elias
On 10/6/2021 3:35 PM, Toyin Falola wrote:
> https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nytimes.com%2F2021%2F10%2F06%2Fhealth%2Fmalaria-vaccine-who.html%3FreferringSource%3DarticleShare&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082251399%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=%2Fk3tRyvt8ACkSYftEAjEZ7ICVmr6XyIZJ6WnLDdxrcA%3D&reserved=0
>
>
> Sent from my iPhone
>
--
Elias Kifon Bongmba PhD, DTheo (Lund)
Harry and Hazel Chair in Christian Theology
Professor of Religion
Chair, Department of Religion
Executive Editor, the Journal of Religion in Africa
Rice university
PO Box 1892 Houston TX 77251-1892
https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Freli.rice.edu%2Ffaculty%2Felias-kifon-bongmba&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=nA3%2B%2Bo9p7q0hmHWcn7Yi6QsKR%2B2E23YLCPR%2FbZ1Ps74%3D&reserved=0
--
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fgroups.google.com%2Fgroup%2FUSAAfricaDialogue&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0M6vig0sRNmRsClmMrU6MoHB7cCkuD44zo0LhfcGVug%3D&reserved=0
Early archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.utexas.edu%2Fconferences%2Fafrica%2Fads%2Findex.html&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3fnQDLspMqd0Omt1D28%2Fq4D%2FZveBoWeQP80%2FT27ssSg%3D&reserved=0
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgroups.google.com%2Fd%2Fmsgid%2Fusaafricadialogue%2F6fad9e72-e5f8-3d82-74de-3b8acdaae1ce%2540rice.edu&data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=EmjeC4o504oz2NJSKQH7LrN4xAbSRePp5FwQhtA11MY%3D&reserved=0.
No comments:
Post a Comment